The unclassifiable category excluded those cases in which the lack of molecular data useful for a correct classification of the disease or a suboptimal histological specimen may impede a correct ...

Ruben Mesa, M.D.,Rami S. Komrokji, M.D. Experts Rami Komrokji, MD, and Ruben Mesa, MD, define myeloproliferative neoplasms (MPNs) and explain differences between ...

Key opinion leaders highlight different testing and workup methods involved in making an accurate diagnosis of myeloproliferative neoplasms. Ruben Mesa, M.D.: Rami (Rami Komrokji, M.D.), how would you ...

There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben ...

A new large-scale study of patients with myeloproliferative neoplasm finds they are at twice the risk of mortality from respiratory disease. Patients with myeloproliferative neoplasm have roughly ...

Please provide your email address to receive an email when new articles are posted on . Riedlinger and colleagues assessed clinical sequencing data on 2,030 solid tumors examined at Rutgers University ...

Despite the enormous progress in our understanding of the accumulation of somatic mutations and the associated genetic complexity of cancer, it is not known whether the order in which mutations in a ...

Please provide your email address to receive an email when new articles are posted on . “What I really took away from his presentation was just all of the ways that the inflammatory background of ...

Myeloproliferative neoplasms (MPNs) are currently diagnosed according to the World Health Organization (WHO) criteria. Molecular profiling should include the analysis of JAK2 V617F (first, exon 12 ...

To check your myeloproliferative neoplasms (MPN) diagnosis and find out the subtype, your physician will do a complete physical exam and ask about your health history and any symptoms. You may also ...

—US incidence rates of myeloproliferative neoplasms, and relative survival, was largely unknown until last year, when NIH-funded research assessed epidemiologic trends between 2001 and 2012. Here’s ...

Myeloproliferative neoplasms are a group of rare disorders of the bone marrow that cause an increase in the number of blood cells. You may also hear doctors call them MPN or myeloproliferative ...